Clinical Study
Effects of Mobility-Enhancing Nursing Intervention in Patients with MS and Stroke: Randomised Controlled Trial
Table 1
Baseline characteristics and medical data.
| | | Intervention group (IG) | Control group (CG) | value |
| | Age in years | 61.8 (14.5) | 62.9 (12.7) | 0.625 | | Female | 32 (45.7%) | 36 (52.9%) | 0.499 | | Diagnosis | | | 0.578 | | SHT | 2 (2.9%) | 3 (4.3%) | | | CVI | 41 (58.6%) | 35 (50%) | | | MS | 27 (45.8%) | 32 (54.2%) | | | EBI score | 40.7 (9.6) | 42.4 (11.7) | 0.349 | | EBI stroke | 36.4 (6.6) | 36.3 (8.6) | 0.943 | | EBI MS | 47.3 (9.9) | 49 (11.7) | 0.570 | | WHOQoL global | 49.6 (25.4) | 56.2 (24.1) | 0.124 | | Fall-related efficacy | 12.7 (4.8) | 13.5 (5.1) | 0.366 | | Self-Care Index (SPI) | 28.5 (6.4) | 30.0 (6.8) | 0.094 | | Length of stay | 39 (24.1) | 34.3 (18.58) | 0.192 | | Discharge destination | | | 0.908 | | Home | 58 (84.1%) | 58 (82.9%) | | | Institution | 9 (13%) | 9 (12.9%) | | | Hospital | 2 (2.9%) | 3 (4.3%) | |
|
|
Data are mean (SD) or (%), unless otherwise stated.
|
